Concepedia

Jingjing Shao

JS

Statistics

Publications

22

Citations

567

H-Index

15

Active since

2014

Affiliations

Nantong University(Current)

Wenzhou Medical University

Hangzhou Medical College

Nantong Tumor Hospital

Affiliated Hospital of Nantong University

Jingjing Shao is an author at Nantong University specializing in medicine, oncology, and pharmacology.

Publications per year

2014–2024

22

Publications

22

Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases

Haowen Xu, Jiahao Chen, Pan Chen et al. · Acta Pharmaceutica Sinica B · 2022 · 88 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and lymphocyte-to-monocyte ratio (LMR) in patients with non-small cell lung cancer after radical lung cancer surgery

Baoqian Zhai, Jia Chen, Jiacheng Wu et al. · Annals of Translational Medicine · 2021 · 78 citations · Full text

Medicine, Oncology, Surgery +15

Discovery of alantolactone as a naturally occurring NLRP3 inhibitor to alleviate NLRP3‐driven inflammatory diseases in mice

Weifeng Li, Haowen Xu, Jingjing Shao et al. · British Journal of Pharmacology · 2023 · 36 citations · Full text

Medicine, Immunology, Pharmacology +17

Synergistic anti-oxidant and anti-inflammatory effects of ceria/resatorvid co-decorated nanoparticles for acute lung injury therapy

Yue Wu, Yawen Zhang, Xuanyu Tang et al. · Journal of Nanobiotechnology · 2023 · 33 citations · Full text

Medicine, Pharmaceutics, Pharmacology +17

Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice

Haowen Xu, Weifeng Li, Shanshan Hong et al. · Acta Pharmacologica Sinica · 2023 · 31 citations · Full text

Life Sciences, Immunology, Pathology +16

1–5 of 22